Current Drug Targets
Title:Editorial (Thematic Issue:Targeting Loss of Tumor Suppressors for Cancer Therapeutics)
Volume: 15 Issue: 1
Author(s): Jenifer R. Prosperi and Kathleen Heppner Goss
Affiliation:
Export Options
About this article
Cite this article as:
Prosperi R. Jenifer and Goss Heppner Kathleen, Editorial (Thematic Issue:Targeting Loss of Tumor Suppressors for Cancer Therapeutics), Current Drug Targets 2014; 15 (1) . https://dx.doi.org/10.2174/138945011501140115104533
DOI https://dx.doi.org/10.2174/138945011501140115104533 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
35
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Potential Association Between TLR4 and Chitinase 3-Like 1 (CHI3L1/YKL-40) Signaling on Colonic Epithelial Cells in Inflammatory Bowel Disease and Colitis-Associated Cancer
Current Molecular Medicine MicroRNA-mediated Regulation of Angiogenesis
Current Angiogenesis (Discontinued) Comparison of Large Proteomic Datasets
Current Proteomics Roles of Natural Compounds from Medicinal Plants in Cancer Treatment: Structure and Mode of Action at Molecular Level
Medicinal Chemistry Tyrosine Kinase Inhibitor-Induced Hypertension: Role of Hypertension as a Biomarker in Cancer Treatment
Current Vascular Pharmacology Bioinformatic Analysis of HIV-1 Entry and Pathogenesis
Current HIV Research Metallopharmaceuticals in Therapy - A New Horizon for Scientific Research
Current Medicinal Chemistry Persistent GP130/STAT3 Signaling Contributes to the Resistance of Doxorubicin, Cisplatin, and MEK Inhibitor in Human Rhabdomyosarcoma Cells
Current Cancer Drug Targets Targeting Angiogenesis in Gastro-Intestinal Non Colorectal Cancers; A Review
Current Angiogenesis (Discontinued) Diamidine Activity Against Trypanosomes: The State of the Art
Current Molecular Pharmacology Recent Studies on Macromolecular Synthesis Labeled with 3H-Thymidine in Various Organs as Revealed by Electron Microscopic Radioautography
Current Radiopharmaceuticals Telomere End Protection in Stem Cells and Cancer Cells
Current Cancer Therapy Reviews Emerging Hsp90 Inhibitors: From Discovery to Clinic
Anti-Cancer Agents in Medicinal Chemistry Radiolabelled Regulatory Peptides for Imaging and Therapy
Anti-Cancer Agents in Medicinal Chemistry Editorial [Hot-Topic:Physical and Chemical Agents Inducing Cell Death and Differentiation (Executive Editor: Roberta Di Pietro)]
Current Pharmaceutical Design Protective Effects of Corticosteroids and Neurosteroids on Cochlear injury
Medicinal Chemistry Molecular Classification of Breast Carcinoma In Situ
Current Genomics Synthesis, Anticancer Evaluation and Docking Study of 3- Benzyloxyhydantoin Derivatives
Medicinal Chemistry Population Pharmacokinetic Evaluation of a Fully Human IgG2 Monoclonal Antibody in Patients with Inflammatory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Smart Biodecorated Hybrid Nanoparticles
Current Bionanotechnology (Discontinued)